A Study of HRS-7535 Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Diet and Exercise

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 284 participants.

Also called NCT06672172

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 284 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06672172
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06672172. Randomized; double masking; primary purpose treatment. Start 2024-09-25 (actual); primary completion 2025-11-13 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of HRS-7535 Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Diet and Exercise
Acronym
OUTSTAND-1
Intervention (Drug)
HRS-7535 tablet
Intervention (Drug)
HRS-7535 tablet
Intervention (Drug)
HRS-7535 tablet
Intervention (Drug)
HRS-7535 placebo tablet
Lead sponsor
Shandong Suncadia Medicine Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct06672172
Content hash
f2cd791c5a81be88bb74c94b042c7f484953205c2b16e2f74640b83fe9bbda9c